Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Hereditary Sensory and Autonomic Neuropathies × PX-866 × Clear all

Phase

Phase 1/2 2 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Carcinoma 1

Interventions

duvelisib 2 volagidemab 1 pembrolizumab 1 palbociclib 1 olaparib 1 obinutuzumab 1 lorlatinib 1 gedatolisib 1 encorafenib 1 chiauranib 1 capivasertib 1 binimetinib 1 berzosertib 1 Radiotherapy 1 PX-866 1 NVP-BKM120 1 Letrozole 1 Fulvestrant 1 Everolimus 1 Cetuximab 1 CYH33 1 BAY 1895344 1 AZD1390 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00726583 2018-05-17

Phase I Trial of Oral PX-866

Seagen Inc.

Phase 1 Completed

Carcinoma, Neoplasms, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡